ClinicalTrials.govpublic full text
Cabergoline Reduces OHSS
ovarian hyperstimulation syndrome, ovarian hyperstimulation syndrome, dopamine agonists, cabergoline, hemoconcentration, ascites, ovarian perfusion, dopamine receptor 2, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 885580
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.